跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
LEVOSIMENDAN ACCORD 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Approved
STANDARD
LEVOSIMENDAN ACCORD 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Accord Healthcare S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 21, 2022
Approval ID
a5b7c0a49d4a8047
Company
Accord Healthcare S.L.U.
Type
Standard
Approval Details
Approval Id
a5b7c0a49d4a8047
Drug Cima Aemps Name
LEVOSIMENDAN ACCORD 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number
86667
Holder Company Name
Accord Healthcare S.L.U.
Marketing Company Name
Accord Healthcare S.L.U.
Holder Company Detail Path
/organization/accord-healthcare-sl
Marketing Company Detail Path
/organization/accord-healthcare-sl
Authorization Date
2022-03-21
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
2,5 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Accord Healthcare S.L.U.
Company Detail Path
/organization/accord-healthcare-sl
Company Information
Pharmaceutical Company Name
ACCORD HEALTHCARE SL
Country Name
Spain
City Name
barcelona,barcelona,country_es
Address
CALLE MOLL BARCELONA (WORLD TRADE CENTER EDIF. ESTE), S/N
Active Ingredients
LEVOSIMENDAN
2,5 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 21, 2022
Approval ID
a5b7c0a49d4a8047
Type
Standard
Back to CIMA-AEMPS Approvals
LEVOSIMENDAN ACCORD 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG - CIMA-AEMPS Drug Approval Details